Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Methyl Quinoxaline-2-carboxylate | Methyl Quinoxaline-2-carboxylate. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-Quinoxalinecarboxylic Acid Methyl Ester, Methyl Quinoxaline-2-carboxylate. CAS No. 1865-11-8. IUPAC Name: methyl quinoxaline-2-carboxylate. Molecular Formula: C10H8N2O2. Mole Weight: 188.18. Catalog: APS1865118. SMILES: COC(=O)c1cnc2ccccc2n1. Format: Neat. Shipping: Room Temperature. |  |
| 1(2H)-Quinoxalinecarboxamide,3,4-dihydro-4-methyl-(6ci) | Heterocyclic Organic Compound. Alternative Names: 1(2H)-Quinoxalinecarboxamide,3,4-dihydro-4-methyl-(6CI);4-METHYL-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXAMIDE. CAS No. 102872-96-8. Molecular formula: C10H13N3O. Catalog: ACM102872968. |  |
| 2,3-Dimethyl-5-nitro-6-methylamino-7-methyl-quinoxaline | 2,3-Dimethyl-5-nitro-6-methylamino-7-methyl-quinoxaline. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 25mg. US Biological Life Sciences. |  Worldwide |
| 2-(4-Methylphenyl)-5-phenyl-1H-[1,2,4]triazino[4,3-a]quinoxaline | Heterocyclic Organic Compound. CAS No. 108310-81-2. Molecular formula: C23H18N4. Mole weight: 350.415820 g/mol. Catalog: ACM108310812. | |
| 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3 | Heterocyclic Organic Compound. Alternative Names: MeIQx-d3; 8-Methyl-3-(methyl-d3)-. CAS No. 122457-31-2. Molecular formula: C11H8D3N5. Mole weight: 216.26. Appearance: Greenish Yellow Solid. Purity: 0.96. IUPACName: 8-methyl-3-(trideuteriomethyl)imidazo[4,5-f]quinoxalin-2-amine. Canonical SMILES: CC1=CN=C2C=CC3=C(C2=N1)N=C(N3C)N. Density: 1.5g/cm³. Catalog: ACM122457312. | |
| 2-Amino-3-methyl-3H-imidazo[4,5-f]quinoxaline | Heterocyclic Organic Compound. Alternative Names: IQX;2-AMINO-3-METHYL-3H-IMIDAZO[4,5-F]QUINOXALINE;3H-Imidazo[4,5-f]quinoxalin-2-amine,3-methyl-(9CI);3H-Imidazo(4,5-F)quinoxalin-2-amine, 3-methyl-;3-Methyl-3H-imidazo(4,5-F)quinoxalin-2-amine. CAS No. 108354-47-8. Molecular formula: C10H9N5. Mole weight: 199.21. Appearance: Brown Solid. Purity: 0.96. IUPACName: 3-methylimidazo[4,5-f]quinoxalin-2-amine. Canonical SMILES: CN1C2=C(C3=NC=CN=C3C=C2)N=C1N. Density: 1.54g/cm³. Catalog: ACM108354478. | |
| 2-Amino-3-methyl-3H-imidazo[4,5-F]quinoxaline (IQx) | Exhibits an extraordinarily high mutagenic potency in the Ames test. Group: Biochemicals. Alternative Names: IQx; 3-Methyl-3H-imidazo[4,5-f]quinoxalin-2-amine; 2-Amino-3-Methylimidazo[4,5-f]quinoxaline. Grades: Highly Purified. CAS No. 108354-47-8. Pack Sizes: 2.5mg. Molecular Formula: C??H?N?, Molecular Weight: 199.21. US Biological Life Sciences. | Worldwide |
| 2-Amino-8-methyl-3- (trideuteromethyl) imidazo[4, 5-f]quinoxaline (MeIQx-d3) | 2-Amino-8-methyl-3- (trideuteromethyl) imidazo[4, 5-f]quinoxaline (MeIQx-d3). Group: Biochemicals. Alternative Names: MeIQx-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 2-Chloro-7-trifluoro methyl quinoxaline | 2-Chloro-7-trifluoro methyl quinoxaline. Group: Biochemicals. Grades: Highly Purified. CAS No. 883-94-3. Pack Sizes: 10mg, 25mg. Molecular Formula: C9H4ClF3N2, Molecular Weight: 232.59. US Biological Life Sciences. | Worldwide |
| 2-Methyl-3- (2', 3'-dihydroxypropyl) quinoxaline | 2-Methyl-3- (2', 3'-dihydroxypropyl) quinoxaline. Group: Biochemicals. Alternative Names: 3-(3-Methyl-2-quinoxalinyl)-1,2-propanediol. Grades: Highly Purified. CAS No. 42015-36-1. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C12H14N2O2. US Biological Life Sciences. | Worldwide |
| 2-Methyl-3- (2, 3-dihydroxypropyl) quinoxaline | A food metabolite. Group: Biochemicals. Grades: Highly Purified. CAS No. 42015-36-1. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| 2-Methyl-7-methylamino-8-amino-quinoxaline | 2-Methyl-7-methylamino-8-amino-quinoxaline. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 250mg. US Biological Life Sciences. | Worldwide |
| 2-Methyl-7-methylamino-8-nitro-quinoxaline | 2-Methyl-7-methylamino-8-nitro-quinoxaline. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 250mg. US Biological Life Sciences. | Worldwide |
| 2-Methyl-7-methylamino-d3-8-nitro-quinoxaline | 2-Methyl-7-methylamino-d3-8-nitro-quinoxaline. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| 2-Methyl-7-methylamino-d3-8-nitro-quinoxaline | Heterocyclic Organic Compound. Alternative Names: 2-METHYL-7-METHYLAMINO-D3-8-NITRO-QUINOXALINE. CAS No. 1020718-63-1. Molecular formula: C10H7D3N4O2. Mole weight: 221.23. Appearance: Dar Red Solid. Catalog: ACM1020718631. | |
| 2-Methyl-8-quinoxalinesulfonyl Chloride | 2-Methyl-8-quinoxalinesulfonyl Chloride. Group: Biochemicals. Grades: Highly Purified. CAS No. 119373-30-7. Pack Sizes: 1g. Molecular Formula: C10H8ClNO2S, Molecular Weight: 241.69. US Biological Life Sciences. | Worldwide |
| 2-Methyldibenzo[f,h]quinoxaline | 2-Methyldibenzo[f,h]quinoxaline. Group: Ligands for functional metal complexes. Alternative Names: 3-Methylphenanthro[9,10-B]Pyrazine. CAS No. 536753-86-3. Product ID: 3-methylphenanthro[9,10-b]pyrazine. Molecular formula: 244.29. Mole weight: C17H12N2. CC1=CN=C2C3=CC=CC=C3C4=CC=CC=C4C2=N1. DCPGBPKLXYETTA-UHFFFAOYSA-N. InChI=1S / C17H12N2 / c1-11-10-18-16-14-8-4-2-6-12 (14) 13-7-3-5-9-15 (13) 17 (16) 19-11 / h2-10H, 1H3. 97%. |  |
| 2-Methylquinoxaline 1,4-Dioxide | Quinoxaline derivative. Bactericidal activity. Group: Biochemicals. Alternative Names: 2-Methylquinoxaline N,N'-dioxide; 2-Methylquinoxaline di-N-oxide; NSC 47509; NSC 47510; NSC 48949. Grades: Highly Purified. CAS No. 6639-86-7. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| 2-Quinoxalinecarboxylicacid, 3-(methylamino)-(9ci) | Heterocyclic Organic Compound. Alternative Names: 2-Quinoxalinecarboxylicacid, 3-(methylamino)-(9CI). CAS No. 122234-53-1. Molecular formula: C10H9N3O2. Catalog: ACM122234531. | |
| 2-Quinoxalinecarboxylic Acid Methyl Ester | 2-Quinoxalinecarboxylic Acid Methyl Ester. Group: Biochemicals. Grades: Highly Purified. CAS No. 1865-11-8. Pack Sizes: 250mg. Molecular Formula: C10H8N2O2, Molecular Weight: 188.18. US Biological Life Sciences. | Worldwide |
| 3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinepropanoic Acid | Intermediate in the production of DMEQ-TAD. Group: Biochemicals. Alternative Names: 6,7-Dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxaline-2-propionic Acid. Grades: Highly Purified. CAS No. 132788-56-8. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| 3,4-Dihydro-6,7-dimethoxy-4-methyl-3-oxo-2-quinoxalinepropanoic Acid Methyl Ester | Intermediate in the production of DMEQ-TAD. Group: Biochemicals. Alternative Names: 6,7-Dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxaline-2-propionic Acid Methyl Ester. Grades: Highly Purified. CAS No. 131426-28-3. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| 3-Amino-4-methyl-4,6,7,8-tetrahydroquinoxaline-2-carbonitrile | Heterocyclic Organic Compound. Alternative Names: 107938-84-1, 2-Quinoxalinecarbonitrile,3-amino-4,6,7,8-tetrahydro-4-methyl-, ACMC-20mb90, AGN-PC-00NHU7, CTK4A5781, AG-D-24010, 2-Quinoxalinecarbonitrile, 3-amino-4,6,7,8-tetrahydro-4-methyl-, 3-AMINO-4-METHYL-4,6,7,8-TETRAHYDROQUINOXALINE-2-CARBONITRILE, 2-Quinoxalinecarbonitrile,3-amino-4,6,7,8-tetrahydro-4-methyl-(9CI);3-AMINO-4-METHYL-4,6,7,8-TETRAHYDROQUINOXALINE-2-CARBONITRILE. CAS No. 107938-84-1. Molecular formula: C10H12N4. Mole weight: 188.229080 [g/mol]. Purity: 0.96. IUPACName: 3-amino-4-methyl-7,8-dihydro-6H-quinoxaline-2-carbonitrile. Catalog: ACM107938841. | |
| 3- methyl -2-quinoxalinecarboxalde hyde | Intermediate for the preparation of 3-Methyl-quinoxaline-2-carboxylic Acid. Group: Biochemicals. Grades: Highly Purified. CAS No. 25519-55-5. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| 3-Methyl-2-quinoxalinecarboxylic acid | 3-Methylquinoxaline-2-carboxylic acid (MQCA) is a major metabolite of olaquindox, an antibiotic and swine growth regulator. Synonyms: 3-methylquinoxaline-2-carboxylic acid. Grades: 98 %. CAS No. 74003-63-7. Molecular formula: C10H8N2O2. Mole weight: 188.18. |  |
| 3-Methyl-2-quinoxalinecarboxylic acid-d4 | 3-Methyl-2-quinoxalinecarboxylic acid-d4 is the deuterium labeled 3-Methyl-2-quinoxalinecarboxylic acid. 3-Methyl-2-quinoxalinecarboxylic acid (MQCA), an important N-oxide reductive metabolite of Quinocetone or Olaquindox, potently inhibits the growth of Chang liver cells through S phase arrest of the cell cycle. Group: Isotope-labeled environmental contaminants. Alternative Names: MQCA-d4. CAS No. 2244217-93-2. Molecular formula: C10H4D4N2O2. Mole weight: 192.21. Appearance: Solid. Purity: ≥99.0%. Canonical SMILES: O=C (C1=NC2=C ([2H])C ([2H])=C ([2H])C ([2H])=C2N=C1C)O. Catalog: ACM2244217932. | |
| 3-Methylquinoxaline-2-carboxylic Acid | A metabolite of Carbadox and Olaquindox. Group: Biochemicals. Alternative Names: 3-Methyl-2-quinoxalinecarboxylic Acid. Grades: Highly Purified. CAS No. 74003-63-7. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| 3-Methylquinoxaline-2-carboxylic Acid-d4 | Isotope labelled metabolite of Carbadox (C175825) and Olaquindox (O515000). Group: Biochemicals. Alternative Names: 3-Methyl-2-quinoxalinecarboxylic Acid-d4. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 4-Methyl-8-quinoxalinesulfonyl Chloride | 4-Methyl-8-quinoxalinesulfonyl Chloride. Group: Biochemicals. Grades: Highly Purified. CAS No. 13982-84-8. Pack Sizes: 500mg. Molecular Formula: C10H8ClNO2S, Molecular Weight: 241.69. US Biological Life Sciences. | Worldwide |
| 5-Methyl-8-quinoxalinesulfonyl Chloride | 5-Methyl-8-quinoxalinesulfonyl Chloride. Group: Biochemicals. Grades: Highly Purified. CAS No. 71322-92-4. Pack Sizes: 10mg. Molecular Formula: C10H8ClNO2S, Molecular Weight: 241.69. US Biological Life Sciences. | Worldwide |
| 6H-Indolo[2,3-b]quinoxaline-6-aceticacid,9-chloro-,2-[1-(4-methylphenyl)ethylidene]hydrazide | Heterocyclic Organic Compound. CAS No. 116990-02-4. Molecular formula: C25H20ClN5O. Catalog: ACM116990024. | |
| 6-Methyl-8-quinoxalinesulfonyl Chloride | 6-Methyl-8-quinoxalinesulfonyl Chloride. Group: Biochemicals. Grades: Highly Purified. CAS No. 21863-51-4. Pack Sizes: 500mg. Molecular Formula: C10H8ClNO2S, Molecular Weight: 241.69. US Biological Life Sciences. | Worldwide |
| 7-Methyl-8-quinoxalinesulfonyl Chloride | 7-Methyl-8-quinoxalinesulfonyl Chloride. Group: Biochemicals. Grades: Highly Purified. CAS No. 17999-75-6. Pack Sizes: 25mg. Molecular Formula: C10H8ClNO2S, Molecular Weight: 241.69. US Biological Life Sciences. | Worldwide |
| Bis (2-methyldibenzo[f, h]quinoxaline) (acetylacetonate)iridium (iII) | Bis (2-methyldibenzo[f, h]quinoxaline) (acetylacetonate)iridium (iII). Group: Organic light-emitting diode (oled) materials. Alternative Names: Bis (2-methyldibenzo[f, h]quinoxaline) (acetylacetonate)iridium (III); (Acetylacetonato)bis(2-methyldibenzo[f, h]quinoxalinato)iridium; Ir(MDQ)2(acac),Bis(2-Methyldibenzo[f,h]quinoxaline)(a. CAS No. 536755-34-7. Product ID: (Z)-4-hydroxypent-3-en-2-one; iridium; 3-methyl-12H-phenanthro[9,10-b]pyrazin-12-ide. Molecular formula: 778.9. Mole weight: C39H30IrN4O2-2. CC1=CN=C2C3= [C-]C=CC=C3C4=CC=CC=C4C2=N1. CC1=CN=C2C3= [C-]C=CC=C3C4=CC=CC=C4C2=N1. CC (=CC (=O) C) O. [Ir]. InChI=1S/2C17H11N2. C5H8O2. Ir/c2*1-11-10-18-16-14-8-4-2-6-12 (14)13-7-3-5-9-15 (13)17 (16)19-11; 1-4 (6)3-5 (2)7; /h2*2-7, 9-10H, 1H3; 3, 6H, 1-2H3; /q2*-1; ; /b; ; 4-3-. LVMYRWNQFBOYFB-DVACKJPTSA-N. 95%+. | |
| Ethyl 3-methyl-2-quinoxalinecarboxylate | Ethyl 3-methyl-2-quinoxalinecarboxylate is an protected metabolite of Carbadox (C175825) an antimicrobial agents. Group: Biochemicals. Alternative Names: 3-(Ethoxycarbonyl)-2-methylquinoxaline; 3-Methyl-2-quinoxalinecarboxylic Acid Ethyl Ester. Grades: Highly Purified. CAS No. 3885-38-9. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Ethyl 3-Methyl-2-quinoxalinecarboxylate-d4 | Ethyl 3-Methyl-2-quinoxalinecarboxylate-d4. Group: Biochemicals. Alternative Names: 3-(Ethoxycarbonyl)-2-methylquinoxaline-d4; 3-Methyl-2-quinoxalinecarboxylic Acid Ethyl Ester-d4. Grades: Highly Purified. Pack Sizes: 1.5mg. US Biological Life Sciences. | Worldwide |
| Methyl 2,3-dichloro-6-quinoxalinecarboxylate | Heterocyclic Organic Compound. Alternative Names: methyl 2,3-dichloroquinoxaline-6-carboxylate, 108258-54-4, methyl 2,3-dichloro-6-quinoxalinecarboxylate, AGN-PC-00O18Y, CTK6J0382, methyl dichloroquinoxalinecarboxylate, MolPort-009-194-605, ANW-73914, SBB101818, ZINC34156883, AKOS005072937, AG-C-12130, GD-0751, MCULE-9766419771, RP14567, AK-71150, KB-114505, 2,3-Dichloro-quinoxaline-6-carboxylic acid methyl ester, 6-Quinoxalinecarboxylic acid, 2,3-dichloro-, methyl ester. CAS No. 108258-54-4. Molecular formula: C10H6Cl2N2O2. Mole weight: 257.08. Purity: 0.96. IUPACName: methyl 2,3-dichloroquinoxaline-6-carboxylate. Canonical SMILES: COC(=O)C1=CC2=C(C=C1)N=C(C(=N2)Cl)Cl. Catalog: ACM108258544. | |
| N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3 | Labeled dG-C8-MeIQx. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Group: Biochemicals. Alternative Names: 2'-Deoxy-8-[(3-(methyl-d3)-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine; dG-C8-MeIQx-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Quinoxaline,1,2,3,4-tetrahydro-2-(1-methyl-2-propenyl)-(9ci) | Heterocyclic Organic Compound. CAS No. 113477-73-9. Catalog: ACM113477739. | |
| Quinoxaline,1,2-dihydro-3-methyl-2-(2-propenyl)-(9ci) | Heterocyclic Organic Compound. CAS No. 113477-68-2. Catalog: ACM113477682. | |
| Quinoxaline,1,4-dihydro-2-isopropyl-3-methyl-(6ci) | Heterocyclic Organic Compound. CAS No. 105338-76-9. Catalog: ACM105338769. | |
| Quinoxaline,2-methyl-3-(2-propenyl)-(9ci) | Heterocyclic Organic Compound. CAS No. 113477-48-8. Catalog: ACM113477488. | |
| (R,R)-(-)-2,3-Bis(t-butylmethylphosphino)quinoxaline, min. 98% (R,R)-QuinoxP* | Ligand for the rhodium-catalyzed, asymmetric hydrogenation of dehydroamino acid esters and α-enamides. Ligand for the rhodium-catalyzed, asymmetric 1,4-addition of arylboronic acids to α,β-unsaturated carbonyl compounds. Ligand for the rhodium-catalyzed, asymmetric alkylative ring opening reaction Ligand for the palladium-catalyzed asymmetric allylic alkylation and amination of racemic substrates. Ligand for the ruthenium-catalyzed asymmetric hydrogenation of ketones. Ligand for the rhodium-catalyzed, asymmetric hydroacylation of 1,1-disubstituted alkenes with aldehydes. Ligand for the silver-catalyzed asymmetric nitroso aldol reaction. Cu-catalyzed enantioconvergent allyllic borylation. Cu-catalyzed enantioselective cyclopropylation. Group: Heterocyclic organic compound. Alternative Names: AK173366; 866081-62-1; (R,R)-(-)-2,3-Bis(tert-butylmethylphosphino)quinoxaline; (R,R)-QuinoxP; (R,R)-(-)-2,3-Bis(t-butylmethylphosphino)quinoxaline. CAS No. 866081-62-1. Molecular formula: C18H28N2P2. Mole weight: 334.384g/mol. IUPACName: (R)-tert-butyl-[3-[tert-butyl(methyl)phosphanyl]quinoxalin-2-yl]-methylphosphane. Canonical SMILES: CC (C) (C)P (C)C1=NC2=CC=CC=C2N=C1P (C)C (C) (C)C. Catalog: ACM866081621. | |
| SB 525334 (SB-525334, 6-(2-(tert-Butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline) | SB 525334 (SB-525334, 6-(2-(tert-Butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline). Group: Biochemicals. Grades: Highly Purified. CAS No. 356559-20-1. Pack Sizes: 10mg, 50mg. Molecular Formula: C21H21N5, Molecular Weight: 343.4. US Biological Life Sciences. | Worldwide |
| (S,S)-(+)-2,3-Bis(t-butylmethylphosphino)quinoxaline, min. 98% (S,S)-QuinoxP* | Ligand for the rhodium-catalyzed, asymmetric hydrogenation of dehydroamino acid esters and α-enamides. Ligand for the rhodium-catalyzed, asymmetric 1,4-addition of arylboronic acids to α,β-unsaturated carbonyl compounds. Ligand for the rhodium-catalyzed, asymmetric alkylative ring opening reaction Ligand for the palladium-catalyzed asymmetric allylic alkylation and amination of racemic substrates. Ligand for the ruthenium-catalyzed asymmetric hydrogenation of ketones. Ligand for the rhodium-catalyzed, asymmetric hydroacylation of 1,1-disubstituted alkenes with aldehydes. Ligand for the silver-catalyzed asymmetric nitroso aldol reaction. Group: Polydentate phosphine ligandsphosphorus catalysts. Alternative Names: (S, S)-(+)-2, 3-Bis(t-butylmethylphosphino)quinoxaline; 1107608-80-9; (S, S)-2, 3-Bis(tert-butylmethylphosphino)quinoxaline; (S, S)-QuinoxP*; SCHEMBL2559367; 2, 3-Bis[(S)-tert-butylmethylphosphino]quinoxaline; J-002473; (S, S)-(+)-2, 3-Bis(tert-butylmethylphosphino)quinoxaline. CAS No. 1107608-80-9. Molecular formula: C18H28N2P2. Mole weight: 334.384g/mol. IUPACName: (S)-tert-butyl-[3-[tert-butyl(methyl)phosphanyl]quinoxalin-2-yl]-methylphosphane. Canonical SMILES: CC (C) (C)P (C)C1=NC2=CC=CC=C2N=C1P (C)C (C) (C)C. Catalog: ACM1107608809. | |
| 1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is patented as a reagent to synthesize quinoxaline derivatives or heterocyclylamine derivatives as PI3 kinase inhibitors. Group: Biochemicals. Grades: Highly Purified. CAS No. 1020174-04-2. Pack Sizes: 250mg, 2.5g. Molecular Formula: C10H17BN2O2, Molecular Weight: 208.07. US Biological Life Sciences. | Worldwide |
| 1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-d3 | 1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-d3 is labelled 1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (M330225) which is patented as a reagent to synthesize quinoxaline derivatives or heterocyclylamine derivatives as PI3 kinase inhibitors. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg, 100mg. Molecular Formula: C10H14D3BN2O2, Molecular Weight: 211.08. US Biological Life Sciences. | Worldwide |
| (1R)-1-[(2S)-1,2-Dihydroquinoxalin-2-yl]ethanol | Heterocyclic Organic Compound. Alternative Names: 111289-53-3, (1R)-1-[(2S)-1,2-DIHYDROQUINOXALIN-2-YL]ETHANOL, ACMC-20me7k, 2-Quinoxalinemethanol,1,2-dihydro-a-methyl-,(R*,S*)- (9CI). CAS No. 111289-53-3. Molecular formula: C10H12N2O. Mole weight: 176.215080 [g/mol]. Purity: 0.96. IUPACName: 1-(1,2-dihydroquinoxalin-2-yl)ethanol. Catalog: ACM111289533. | |
| 3',5'-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-methyl-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Synonyms: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Molecular formula: C33H50N10O4Si2. Mole weight: 706.99. | |
| 3,5-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-methyl-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx (D29615) derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Group: Biochemicals. Alternative Names: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| 3',5'-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-(methyl-d3)-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx-d3 derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Synonyms: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3. Molecular formula: C33H47D3N10O4Si2. Mole weight: 710. | |
| 3,5-Di-O-tert-butyldimethylsilyl-2'-deoxy-8-[(3-(methyl-d3)-8-methyl-3H-imidazo[4,5-f]quinoxalin-2-yl)amino]guanosine | dG-C8-MeIQx-d3 derivative. MeIQx-DNA adducts exist in human tissues and this adduct formation may be involved in human cancer development. Group: Biochemicals. Alternative Names: N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| 3-Bromomethyl-6,7-dimethoxy-1-methyl-2(H)-quinoxalinone | Heterocyclic Organic Compound. Alternative Names: BR-DMEQ;3-BROMOMETHYL-6,7-DIMETHOXY-1-METHYL-2(H)-QUINOXALINONE;3-BROMOMETHYL-6,7-DIMETHOXY-1-METHYL- 2(1H)-CHINOXALINONE*;3-Bromomethyl-6,7-dimethoxy-1-methyl-1,2-dihydroquinoxaline-2-one;3-bromomethyl-6,7-dimethoxy-1-methyl-2(1H)-quinoxalinone;3-BROMOM. CAS No. 100595-07-1. Molecular formula: C12H13BrN2O3. Mole weight: 313.15. Catalog: ACM100595071. | |
| 3-Chloro-4-nitrotoluene | 3-Chloro-4-nitrotoluene is used in the synthesis of quinoxaline derivatives in the development of a positron emission tomography radiotracer for the imaging of N-Methyl-D-aspartate receptor (NMDAR). Group: Biochemicals. Grades: Highly Purified. CAS No. 38939-88-7. Pack Sizes: 250mg, 1g. Molecular Formula: C7H6ClNO2, Molecular Weight: 171.58. US Biological Life Sciences. | Worldwide |
| 5-Chloro-6-methyl-4-nitro-2,1,3-benzoselenadiazole | Intermediate in the synthesis of mutagenic methyl substituted 2-amino-3H-imidazo[4,5-f]quinoxalines. Group: Biochemicals. Grades: Highly Purified. CAS No. 147021-84-9. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| AKT inhibitor VIII | Akt Inhibitor VIII is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity. It does not exhibit any inhibitory effect against pleckstrin homology (PH) domain-lacking Akts, AGC family kinases, PKA, PKC or SGK. It also prevails over Akt1/Akt2-mediated resistance to chemotherapeutics in tumor cells and has been shown to block basal and stimulated phosphorylation/activation of Akt1/Akt2 in cultured cells and in mice. Synonyms: AKT inhibitor VIII; AKT-inhibitor-VIII; AKT inhibitor-8; AKT-inhibitor-8; Akt-I 1,2; Akti-1/2. Sigma-A6730. 2H-Benzimidazol-2-one, 1,3-dihydro-1-[1-[[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methyl]-4-piperidinyl]-. Grades: >98%. CAS No. 612847-09-3. Molecular formula: C34H29N7O. Mole weight: 551.64. | |
| B220 | B220 is an antiviral agent which can inhibit the growth of HSV-1, HSV-2 and human cytomegalovirus (CMV). Synonyms: 112228-65-6|B220|6H-Indolo(2,3-b)quinoxaline-6-ethanamine, N,N,2,3-tetramethyl-|2-(2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-N,N-dimethylethanamine|6H-Indolo[2,3-b]quinoxaline-6-ethanamine, N, N, 2, 3-tetra methyl -|Oprea1_679137|CHEMBL456589|SCHEMBL1 581068|ZINC24937|DTXSID40920692|9-OH-B220|NSC811922|NSC-811922|HY-100272|B 220|B-220|CS-0018424|2,3-dimethyl-6(2-dimethylaminoethyl)-6h-indolo-(2,3-b)quinoxaline|2,3-Dimethyl-N,N-dimethylaminoethyl-5H-indolo(2,3-b)quinoxaline|N,N,2,3-Tetramethyl-6H-indolo[2,3-b]quinoxaline-6-ethane-1-amine|2-(2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-N,N-dimethyl-ethanamine|2,3-Dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6H-indolo-(2,3-b)quinoxaline|2-(2,3-Dimethyl-6H-indolo[2,3-b]quinoxalin-6-yl)-N,N-dimethylethan-1-amine|112229-05-7. Grades: ≥99.0%. CAS No. 112228-65-6. Molecular formula: C20H22N4. Mole weight: 318.42. | |
| BMS 180680 | BMS 180680 is antibacterial activity agent of new catechol-containing monobactam. It is a cell wall inhibitor. BMS-180680 is an active compound against many species of the family Enterobacteriaceae, with MICs at which 90% of the isolates were inhibited. In Oct 2002, Phase-II for Respiratory tract infections in USA was discontinued. Uses: Respiratory tract infections. Synonyms: BMS 180680; BMS180680; BMS-180680; SQ 84,100;(2R-(2alpha,3alpha(Z)))-3-((((1-(2-Amino-4-thiazolyl)-2-((2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino)-2-oxoethylidene)amino)oxy)methyl)-6,7-dihydroxy-2-quinoxalinecarboxylic acid. Grades: 98%. CAS No. 142654-34-0. Molecular formula: C19H17N7O10S2. Mole weight: 567.51. | |
| Carbadox | Antimicrobial. Group: Biochemicals. Alternative Names: (2-Quinoxalinylmethylene) hydrazinecarboxylic Acid Methyl Ester N,N'-Dioxide; 2-Formylquinoxaline-1,4-dioxide Carbomethoxyhydrazone; Fortigro; GS 6244; Getroxel; Mecadox. Grades: Highly Purified. CAS No. 6804-7-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Carbadox-d3 | Antimicrobial. Group: Biochemicals. Alternative Names: (2-Quinoxalinylmethylene) hydrazinecarboxylic Acid Methyl-d3 Ester N,N'-Dioxide; 2-Formylquinoxaline-1,4-dioxide Carbomethoxyhydrazone-d3; Fortigro-d3; GS 6244-d3; Getroxel-d3; Mecadox-d3. Grades: Highly Purified. CAS No. 1185240-06-5. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Cgs-12066a maleate salt | Heterocyclic Organic Compound. Alternative Names: CGS-12066A maleate salt;4-(4-Methyl-1-piperazinyl)-7-(trifluoromethyl)-pyrrolo[1,2-a]quinoxaline. CAS No. 109028-09-3. Molecular formula: C17H17F3N4. Mole weight: 450.41. Appearance: Solid. Purity: 0.96. IUPACName: 4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline. Canonical SMILES: CN1CCN (CC1)C2=NC3=C (C=CC (=C3)C (F) (F)F)N4C2=CC=C4. Catalog: ACM109028093. | |
| CGS 12066B dimaleate | CGS 12066B dimaleate is a 5-HT1B full agonist, which is 10-fold selective over 5-HT1A and 1000-fold selective over 5-HT2C receptors. Uses: Serotonin receptor agonists. Synonyms: CGS 12066B dimaleate; CGS12066B dimaleate; CGS-12066B dimaleate; 7-Trifluoromethyl-4-(4-methyl-1-piperazinyl)pyrrolo[1,2-a]-quinoxaline dimaleate. Grades: ≥98% by HPLC. CAS No. 109028-10-6. Molecular formula: C17H17F3N4.2C4H4O4. Mole weight: 566.49. | |
| CP-481715 | CP-481715 is a potent and selective CCR1 antagonist with >100-fold selective for CCR1 as compared with a panel of G-protein-coupled receptors including related chemokine receptors. CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice. Synonyms: N-[(2S,3S,5R)-5-carbamoyl-1-(3-fluorophenyl)-3,8-dihydroxy-8-methylnonan-2-yl]quinoxaline-2-carboxamide; CP 481,715; CP 481715; CP-481,715; CP-481715; CP481,715; CP481715; quinoxaline-2-carboxylic acid (4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyloctyl)amide. Grades: >98%. CAS No. 212790-31-3. Molecular formula: C26H31FN4O4. Mole weight: 482.55. | |
| Echinomycin | It is produced by the strain of Streptomyces echinatus. It has the activity of anti-gram-positive bacteria and vaginal trichomonas, and also has the effect on influenza virus and sarcoma 180 cells in vitro. Synonyms: Quinomycin A; Levomycin; N,N'-((1R,4S,7R,11S,14R,17S,20R,24S)-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane-7,20-diyl)bis(quinoxaline-2-carboxamide); N-(2-Quinoxalinylcarbonyl)-O-[N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-3-mercapto-N,S-dimethylcysteinyl-N-methyl-L-valyl]-D-seryl-L-alanyl-N-methylcysteinyl-N-methyl-L-valine-(81)-lactone-cyclic(37)-thioether; Antibiotic A 654I; NSC 13502; NSC 526417. Grades: >99% by HPLC. CAS No. 512-64-1. Molecular formula: C51H64N12O12S2. Mole weight: 1101.25. | |
| Enfuvirtide acetate | Enfuvirtide (T20; DP178) acetate is an anti-HIV-1 fusion inhibitor peptide. Group: Inhibitors. CAS No. 914454-00-5. Molecular formula: C206H305N51O66. Mole weight: 4552.62. Appearance: Solid. Purity: 0.96. IUPACName: 2-(3,5-dimethylpyrazol-1-yl)-3-(4-methylpiperazin-1-yl)quinoxaline. Canonical SMILES: CC1=CC (=NN1C2=NC3=CC=CC=C3N=C2N4CCN (CC4)C)C. Catalog: ACM914454005. | |
| glecaprevir | Glecaprevir is a suppressive agent of hepatitis C virus (HCV). Glecaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 4.09 μM. Uses: The treatment of hepatitis c virus (hcv) infection. Synonyms: ABT 493; (3aR, 7S, 10S, 12R, 21E, 24aR) -7-tert-butyl-N-[ (1R, 2R) -2- (difluoromethyl) -1-{[ (1-methylcyclopropyl) sulfonyl]carbamoyl}cyclopropyl]-20, 20-difluoro-5, 8-dioxo-2, 3, 3a, 5, 6, 7, 8, 11, 12, 20, 23, 24a-dodecahydro-1H, 10H-9, 12-methanocyclopenta[18, 19][1, 10, 17, 3, 6]trioxadiazacyclononadecino[11, 12-b]quinoxaline-10-carboxamide. Grades: 98%. CAS No. 1365970-03-1. Molecular formula: C38H46F4N6O9S. Mole weight: 838.87. | |
| Glucagon-Like Peptide 1 Receptor Agonist | A nonpeptidic quinoxaline compound that acts as a GLP-1R agonist and an allosteric modulator of GLP-1 binding. Shown to induce GLP-1R-mediated cAMP production in BHK plasma membrane preparations (EC50=101nM) and potentiate glucose-dependent insulin release in pancreatic islets derived from wild-type, but not GLP-1R -/-, mice. Unlike GLP-1, its biological activity is not inhibited by orthosteric antagonists such as Exendin. Group: Biochemicals. Alternative Names: 6,7-dichloro-N-(1,1-dimethylethyl)-3-(methylsulfonyl)-, 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline (DMB); Compound 2; GLP-1R Agonist. Grades: Highly Purified. CAS No. 281209-71-0. Pack Sizes: 5mg. Molecular Formula: C??H??Cl?N?O?S, Molecular Weight: 348.3. US Biological Life Sciences. | Worldwide |
| MeIQx | MeIQx, also known as 8-Methyl-IQX, is a synthetic, pale orange to brown crystalline solid that is soluble in dimethylsulfoxide and methanol. It is produced in small quantities for research purposes. 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline is formed naturally during the cooking of muscle-derived foods (meat and fish). Levels of this chemical produced in this manner are dependent on cooking temperature, cooking time and method of cooking (direct or indirect). It is one of the most abundant heterocyclic amines in a typical Western diet. 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline has also been detected in processed food flavorings, beer, wine, and cigarette smoke. It is reasonably anticipated to be a human carcinogen. Group: Others. Alternative Names: 8-Methyl-IQX; MeIQx. CAS No. 77500-04-0. Molecular formula: C11H11N5. Mole weight: 213.24. Appearance: Solid powder. Purity: >98%. IUPACName: 3,8-Dimethyl-3H-imidazo(4,5-f)quinoxalin-2-amine. Canonical SMILES: NC1=NC2=C3N=C(C)C=NC3=CC=C2N1C. Catalog: ACM77500040. | |
| Methyl Varenicline | Methyl Varenicline is a derivative of Varenicline. Varenicline is a partial agonist of nicotinic receptor used for smoking cessation. It reduces both the desire for and the pleasure of cigarettes. Synonyms: Varenicline Impurity 3; 2-Methyl-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline. CAS No. 1333145-89-3. Molecular formula: C14H15N3. Mole weight: 225.3. | |
| N,2,7-Trimethyl-5-nitro-6-quinoxalinamine-d3 | Intermediate in the synthesis of mutagenic methyl substituted 2-amino-3H-imidazo[4,5-f]quinoxalines. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
